Thrombolysis for acute myocardial infarction in early post-renal transplant period: A case report

  • V.K.B. Bandi Sri Ramachandra Medical College
  • M.S. Shekar Sri Ramachandra Medical College
  • R.E. Elumalai Sri Ramachandra Medical College
  • V.M. Mamidi Sri Ramachandra Medical College
  • V.K.M. Makkena Sri Ramachandra Medical College https://orcid.org/0000-0003-2286-7863
Keywords: myocardial infarction, renal transplant, thrombolysis

Abstract

Cardiovascular disease is a major contributor to morbidity and has become the leading cause of death among renal transplant patients. This paper presents a case of acute myocardial infarction occurring three weeks after a renal transplant. A 45-year-old male recipient experienced acute chest pain, hypotension, and atrial fibrillation, leading to a diagnosis of inferior-posterior wall myocardial infarction. Thrombolysis with Tenectaplase was administered, resulting in the development of a perinephric hematoma six hours later. The patient underwent transfusions and pigtail drainage of the hematoma. Following hematoma resolution, the pigtail catheter was removed, and the patient was started on dual anti-platelets. Upon discharge, the patient exhibited stable renal function. In conclusion, thrombolysis in the early post-transplant period poses significant risks. This case highlights the use of thrombolytic therapy during this period and the successful management of associated complications.

Downloads

Download data is not yet available.

References

Sertić Z, Letilović T, Kanižaj TF, Knotek M, Hadžibegović I, Starovečki I, et al. Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution. Medicine (Baltimore). 2021;100(20):e26019. doi: 10.1097/MD.0000000000026019.

Aakhus S, Dahl K, Wideroe T. Cardiovascular Morbidity and Mortality in Renal Transplant Recipients. Nephrol Dial Transplant. 1999; 14:648-654. doi:10.1093/ndt/14.3.648.

Lindholm A, Albrechtsen D, Frodin L, Turfveson G, Person Nh, Lundgren G. Ischemic Heart Disease-Major Cause of Death and Graft Loss After Renal Transplantation In Scandinavia. Transplantation. 1995; 60: 451-457. doi:10.1097/00007890-199509000-00008.

Rao VK. Posttransplant medical complications. Surg Clin North Am. 1998; 78: 113-132.  doi:10.1016/s0039-6109(05)70638-1.

Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL Jr, et al.  Controlling The Epidemic Of Cardiovascular Disease In Chronic Renal Disease: What Do We Know? What Do We Need To Learn? Where Do We Go From Here? National Kidney Foundation Task Force On Cardiovascular Disease. Am J Kidney Dis. 1998; 32: 853–906.  doi:10.1016/s0272-6386(98)70145-3.

Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A.  Risk Factors For Late Kidney Allograft Failure. Kidney Int. 2002; 62: 1848–1854. doi: 10.1046/j.1523-1755.2002.00612.x.

Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular Disease After Renal Transplantation. J Am Soc Nephrol. 1996; 7: 158–165. doi:10.1681/ASN.V71158.

Kramer BK, Zulke C, Kammerl MC, Schmidt C, Hengstenberg C, Fischereder M, Marienhagen J. Cardiovascular Risk Factors And Estimated Risk For CAD In A Randomized Trial Comparing Calcineurin Inhibitors In Renal Transplantation. Am J Transplant. 2003; 3: 982–987. doi:10.1034/j.1600-6143.2003.00156.x.

Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, Kaplan B. Mycophenolate Mofetil Versus Azathioprine Therapy Is Associated With A Significant Protection Against Long-Term Renal Allograft Function Deterioration. Transplantation. 2003; 75: 1341–1346. doi:10.1097/01.TP.0000062833.14843.4B.

Moore R, Boucher A, Carter J, Kim SJ, Kiberd B, Loertscher R, et al. Diabetes Mellitus In Transplantation: 2002 Consensus Guidelines. Transplant Proc. 2003; 35: 1265–1270. doi:10.1016/s0041-1345(03)00434-2.

Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient Survival After Renal Transplantation: IV. Impact Of Post-Transplant Diabetes. Kidney Int. 2002; 62:1440–1446. doi:10.1111/j.1523-1755.2002.kid582.x.

Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. 2019;32(3):389-399. doi: 10.1007/s40620-018-0549-4.

Stewart G, Jardine AG, Briggs JD. Ischaemic heart disease following renal transplantation. Nephrol Dial Transplant. 2000; 15: 269-277. doi:10.1093/ndt/15.2.269.

D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA. 2001; 286: 180–187. doi:10.1001/jama.286.2.180.


Abstract views: 312
PDF Downloads: 274
Published
2023-08-23
How to Cite
V.K.B. Bandi, Shekar, M., Elumalai, R., Mamidi, V., & Makkena, V. (2023). Thrombolysis for acute myocardial infarction in early post-renal transplant period: A case report. Ukrainian Journal of Nephrology and Dialysis, (4(80), 3-6. https://doi.org/10.31450/ukrjnd.4(80).2023.01